Player FM - Internet Radio Done Right
16,418 subscribers
Checked 3d ago
추가했습니다 five 년 전
Advisory Board에서 제공하는 콘텐츠입니다. 에피소드, 그래픽, 팟캐스트 설명을 포함한 모든 팟캐스트 콘텐츠는 Advisory Board 또는 해당 팟캐스트 플랫폼 파트너가 직접 업로드하고 제공합니다. 누군가가 귀하의 허락 없이 귀하의 저작물을 사용하고 있다고 생각되는 경우 여기에 설명된 절차를 따르실 수 있습니다 https://ko.player.fm/legal.
Player FM -팟 캐스트 앱
Player FM 앱으로 오프라인으로 전환하세요!
Player FM 앱으로 오프라인으로 전환하세요!
Radio Advisory
모두 재생(하지 않음)으로 표시
Manage series 2762568
Advisory Board에서 제공하는 콘텐츠입니다. 에피소드, 그래픽, 팟캐스트 설명을 포함한 모든 팟캐스트 콘텐츠는 Advisory Board 또는 해당 팟캐스트 플랫폼 파트너가 직접 업로드하고 제공합니다. 누군가가 귀하의 허락 없이 귀하의 저작물을 사용하고 있다고 생각되는 경우 여기에 설명된 절차를 따르실 수 있습니다 https://ko.player.fm/legal.
A top podcast for healthcare leaders, with over one million downloads, Radio Advisory is your weekly download on how to untangle the industry's most pressing challenges to help leaders like you make the best business decisions for your organization. From unpacking major trends in care delivery—like site-of-care shifts and the rise of high-cost drugs—to demystifying stakeholder dynamics, to shining a spotlight on priorities that may get overlooked, we're here to help. Our hosts and seasoned researchers talk with industry experts to equip you with knowledge to confront today's unanswered questions in healthcare. New episodes drop every Tuesday. | www.advisory.com
…
continue reading
290 에피소드
모두 재생(하지 않음)으로 표시
Manage series 2762568
Advisory Board에서 제공하는 콘텐츠입니다. 에피소드, 그래픽, 팟캐스트 설명을 포함한 모든 팟캐스트 콘텐츠는 Advisory Board 또는 해당 팟캐스트 플랫폼 파트너가 직접 업로드하고 제공합니다. 누군가가 귀하의 허락 없이 귀하의 저작물을 사용하고 있다고 생각되는 경우 여기에 설명된 절차를 따르실 수 있습니다 https://ko.player.fm/legal.
A top podcast for healthcare leaders, with over one million downloads, Radio Advisory is your weekly download on how to untangle the industry's most pressing challenges to help leaders like you make the best business decisions for your organization. From unpacking major trends in care delivery—like site-of-care shifts and the rise of high-cost drugs—to demystifying stakeholder dynamics, to shining a spotlight on priorities that may get overlooked, we're here to help. Our hosts and seasoned researchers talk with industry experts to equip you with knowledge to confront today's unanswered questions in healthcare. New episodes drop every Tuesday. | www.advisory.com
…
continue reading
290 에피소드
모든 에피소드
×R
Radio Advisory


1 262: The price of policy: How tariffs are reshaping purchasing 33:41
33:41
나중에 재생
나중에 재생
리스트
좋아요
좋아요33:41
For health system leaders, managing the cost of purchased goods is no longer just a budgeting exercise—it’s a strategic necessity. As margins tighten and supply chain disruptions persist, health systems are rethinking everything from vendor relationships to value analysis. In this episode of Radio Advisory, host Rachel (Rae) Woods welcomes Advisory Board expert Nick Hula to unpack the findings of the 2025 Health System Purchasing Survey. Together, they explore how economic and policy pressures are reshaping purchasing strategies across the industry. Nick shares how leaders are balancing short-term cost-saving tactics with long-term resilience, and why holistic evaluation—factoring in real-world outcomes, clinician experience, and supply chain security—is becoming the new standard. We’re here to help: Survey results: Insights on health system purchasing today 20 ways health systems can control costs Resources to build a modern and resilient supply chain How supply chain leaders should (and shouldn't) respond to tariffs How purchasers are tackling the affordability crisis of high-cost drugs Ep. 259: Our expensive new normal: why traditional drug cost controls are obsolete In times of uncertainty, it’s easy to feel overwhelmed by what’s out of your control. That’s why over the next few weeks we’re revisiting three powerful conversations that remind us where to focus: on operational excellence, on what is within your control, and on the urgency to act now. Don’t miss Radio Advisory’s operational excellence series, beginning August 19th. Send a voice message to Radio Advisory. A transcript of this episode as well as more information and resources can be found on RadioAdvisory.advisory.com.…
R
Radio Advisory


1 261: Maven Clinic on how holistic women's health is the key to reducing cost and engaging employees 40:05
40:05
나중에 재생
나중에 재생
리스트
좋아요
좋아요40:05
For health care purchasers, women’s health is no longer a niche offering—it’s a strategic imperative. In this episode of Radio Advisory, host Rachel (Rae) Woods welcomes Dr. Neel Shah, Chief Medical Officer at Maven Clinic—the world’s largest virtual clinic for women’s and family health—to unpack the clinical, financial, and operational benefits of investing in holistic women’s health. As costs rise, employee expectations evolve, and working parents face mounting pressures, purchasers are navigating a complex balancing act: managing their own financial health while offering benefits that attract and retain top talent. Dr. Shah explains how partners like Maven are helping employers and purchasers offer holistic, cost-effective care across the full lifecycle—from fertility and pregnancy to postpartum and menopause. What you’ll learn in this episode: Why women’s health is a critical component of any cost-containment strategy for purchasers How holistic support for women and parents creates a competitive advantage in today’s labor market The role of digital health in connecting patients and employees to the clinical and non-clinical support they need—quickly and cost-effectively We’re here to help: The Preprint Ep. 216: Ep. 216: Why providers and employers need to focus on women's health "beyond the bikini" Ep. 188: The business case for investing in women's health Ep. 232: The rise of ICHRAs: Why some employers are turning to the individual market Health System Growth Series A transcript of this episode as well as more information and resources can be found on RadioAdvisory.advisory.com.…
R
Radio Advisory


1 260: What does progress in behavioral healthcare look like? Three leaders weigh in 48:48
48:48
나중에 재생
나중에 재생
리스트
좋아요
좋아요48:48
To make progress on delivering behavioral healthcare at scale, we have to hold up examples of what progress looks like—and unpack how we achieve it. That was the goal of our live panel discussion at the Advisory Board Summit in Washington, D.C., moderated by Radio Advisory co-host Abby Burns. In today’s episode of Radio Advisory, hear Abby’s conversation with three provider leaders—Dr. Tristan Gorrindo, former Chief Medical Officer of Optum Behavioral Care, Dr. Mustafa Mufti, Chair of Psychiatry at ChristianaCare, and Dr. Ken Rogers, Chief Medical Officer for Behavioral Health at WellSpan. The group explores how each of these provider organizations are approaching digital health, workforce, crisis care, and, of course, financial sustainability in behavioral health. We’re here to help: Behavioral health Your behavioral health and VBC strategies should work together. Here's why. How GRAND Mental Health reduced psychiatric inpatient hospitalizations by 93% Ep. 187: ChristianaCare's comprehensive, CFO-approved approach to behavioral healthcare Health System Growth Series A transcript of this episode as well as more information and resources can be found on RadioAdvisory.advisory.com.…
R
Radio Advisory


1 259: Our expensive new normal: why traditional drug cost controls are obsolete 32:19
32:19
나중에 재생
나중에 재생
리스트
좋아요
좋아요32:19
Treatments like cell and gene therapies (CGTs) and GLP-1s are transforming care, but with double-digit growth in drug spend year over year, this transformation comes with an unsustainable price tag. And it’s putting pressure on every part of the healthcare ecosystem, from patients and providers to employers and health plans. The strategies that purchasers have used to manage drug spend in the past are no longer getting the job done. But when our Advisory Board experts set out to find the innovators creating new ways to rein in spend, they came up empty. Purchasers appear to be stuck in a “wait and see” pattern—but no silver bullets are coming. This week, host Abby Burns invites Advisory Board experts Chloe Bakst, Aaron Hill, and Amanda Okaka to discuss the drivers behind rising drug costs and why traditional cost-saving strategies are falling short. They provide actionable guidance on how purchasers and plans can modernize their approach to utilization management and make moves toward integrating pharmacy and medical benefits in order to manage total cost of care—in other words, move toward value. What You'll Learn in This Episode: Why drug spend is rising unsustainably Why the current efforts to improve drug affordability are helping, but not enough What it would look like to bring traditional strategies to manage spend into the 2020s What’s on the horizon: the move toward tying drug spend to value We’re here to help: How purchasers are tackling the affordability crisis of high-cost drugs 4 ways pharma can improve partnerships for cell and gene therapy delivery Cell and gene therapy programs: How to launch, optimize, and deliver CGTs sustainably Health Technology Pipeline (HTP) Survey insights: What to know about the clinician workforce today A transcript of this episode as well as more information and resources can be found on RadioAdvisory.advisory.com.…
R
Radio Advisory


1 258: The ‘One Big, Beautiful Bill Act’: What’s changing, who’s affected, and what to do now 6:12
6:12
나중에 재생
나중에 재생
리스트
좋아요
좋아요6:12
On July 4th, 2025, President Donald Trump signed the “One Big Beautiful Bill Act” into law. In this “minisode,” host Rachel (Rae) Woods unpacks the sweeping implications of the most significant healthcare legislation since the Affordable Care Act. From enhanced subsidies expiring to major cuts to Medicaid and ACA marketplace coverage on the horizon, Rae explores what this legislation means for providers, payers, and the broader healthcare ecosystem. Listen to this short policy update for strategic steps leaders must take to manage the cascading impacts of the Act’s implementation. This episode was recorded on July 7th, 2025. We’re here to help: Healthcare Policy Updates Timeline Ep. 256: How you can prepare for the financial impacts of Trump-era policies A transcript of this episode as well as more information and resources can be found on RadioAdvisory.advisory.com.…
R
Radio Advisory


1 257: Paul Markovich on new builds, breakups, and bold healthcare bets 46:12
46:12
나중에 재생
나중에 재생
리스트
좋아요
좋아요46:12
In this special live episode from the 2025 Advisory Board Summit, host Rachel (Rae) Woods sits down with a leader well-versed in bold transformation: Paul Markovich. After more than a decade as President and CEO of Blue Shield of California, Paul now leads Ascendiun—a new nonprofit parent company that includes Blue Shield of California, its clinical services firm Altais, and the newly launched health services business, Stellarus. Together, they explore the mounting pressures facing health plans and the bold bets Paul has made in pursuit of a powerful mission: to eagerly create a healthcare system that is worthy of friends and family—and sustainably affordable. Upholding that mission while navigating constant disruption is no easy feat. In this episode, you’ll learn: How organizations can drive radical change without losing public trust What action steps leaders can take today, from getting their digital house to restructuring their pharmacy models What it takes to prioritize, scale, and sustain bold moves across a complex organization We’re here to help: Ascendiun Blue Shield of California is ditching its PBM. Here's our take. Radio Advisory's Leadership playlist Understand your customer: Health plans Home - 2025 Advisory Board Virtual Summit Series There are two events remaining in the 2025 Advisory Board Summit Series. Click here to learn more and secure your spot. Advisory Board Fellowship A transcript of this episode as well as more information and resources can be found on RadioAdvisory.advisory.com.…
R
Radio Advisory


1 256: How you can prepare for the financial impacts of Trump-era policies 31:07
31:07
나중에 재생
나중에 재생
리스트
좋아요
좋아요31:07
Healthcare executives are closely watching legislative activity in Congress—anticipating shifts in government-funded insurance, new economic headwinds, and regulatory changes. And while change is certainly coming, what remains uncertain is how these forces will shape market dynamics and organizational finances. To help hospitals and health systems prepare, Advisory Board’s quantitative experts developed an impact estimator to size the financial impact of Congress’s ‘One Big Beautiful Bill’. This week, host Abby Burns invites Advisory Board experts Sebastian Beckmann, Deeksha Aleti, and Vidal Seegobin to share the scenario planning tool and explore the range of potential outcomes—from moderate disruption to catastrophic margin impact. Together, they explain how leaders can predict the total impact on their organizations, break down how specific policies will shift their finances (and when), and offer actionable strategies leaders can take today to mitigate risk and plan effectively. We’re here to help: Ep. 255: Is healthcare really recession-proof? Ep. 244: What’s happened in Washington (so far) and what policy changes we’re bracing for Healthcare policy updates 4 ways to improve site-of-care transitions for sickle cell patients How VCU built an ‘inescapable’ Adult Sickle Cell Medical Home to improve inpatient to outpatient transitions of care 4 keys to success in the New England Sickle Cell Institute’s outpatient program for adult sickle cell patients Get in touch to learn more about Advisory Board's Policy Scenario Impact Calculator and other tools A transcript of this episode as well as more information and resources can be found on RadioAdvisory.advisory.com.…
R
Radio Advisory


When experts warn that the economy could be headed for a recession, people working across different corners of the economy get nervous. People working in healthcare, maybe less so. That’s because of a longstanding idea that healthcare is impervious to recession. Okay, maybe that’s overstating it. Healthcare is less susceptible than other industries. But did this notion hold up during the pandemic? During the Great Recession? More importantly, will it hold up now? This week on Radio Advisory, host Rachel (Rae) Woods invites Advisory Board Research Vice Presidents Shay Pratt and Vidal Seegobin to debate the question: Is healthcare really recession-proof? We are not economists, we are healthcare experts. So throughout the conversation, they reflect on how past dislocations affected the healthcare industry, and what leaders can—and can’t—learn from these events to help them interpret the current turbulence. Plus, stay tuned to the end of the episode for a policy update on the ripple effects of Secretary Kennedy’s recent shakeup of the CDC’s vaccine advisory committee. We’re here to help: Listen: Ep. 244: What’s happened in Washington (so far) and what policy changes we’re bracing for Read: Healthcare policy updates Read: How the Great Recession impacted inpatient utilization Read: Could a recession be good for healthcare? Some economists think so. Additional resources related to the Advisory Committee on Immunization practices: Meet the new members of CDC's vaccine advisory panel Understanding the ACIP and How Vaccine Recommendations are Made in the US 4 ways to improve site-of-care transitions for sickle cell patients How VCU built an 'inescapable' Adult Sickle Cell Medical Home to improve inpatient to outpatient transitions of care 4 keys to success in the New England Sickle Cell Institute's outpatient program for adult sickle cell patients Health policy playlist Modeling Reemergence of Vaccine-Eliminated Infectious Diseases Under Declining Vaccination in the US | Infectious Diseases | JAMA | JAMA Network A transcript of this episode as well as more information and resources can be found on RadioAdvisory.advisory.com.…
R
Radio Advisory


1 254: Stop searching for the “perfect” AI product and do this instead 29:31
29:31
나중에 재생
나중에 재생
리스트
좋아요
좋아요29:31
Artificial intelligence (AI) continues to generate excitement across healthcare, promising to reduce clinician burnout, fuel innovation, and ease financial pressures. But despite the hype, AI is far from a “plug-and-play” solution—and simply investing in AI won’t guarantee success. This week, host Rachel (Rae) Woods is joined by Advisory Board AI expert Ty Aderhold to explore what it really takes to see value from AI in healthcare. Together, they unpack: The current reality of AI’s return on investment The hidden risks—like bias, hallucinations, and uneven adoption—that leaders must manage Why leaders should resist the urge to merely copy others How to build the internal capabilities and governance needed for sustainable, high-impact AI adoption Instead of chasing the latest tech trend, leaders should take a problem-first approach—investing in the right governance, expertise, and evaluation to ensure AI solutions are aligned with their organization’s needs. Links: Ep. 220: Why AI in healthcare is more than just ChatGPT Upcoming webinar: AI in healthcare: Use cases, emerging risks, opportunities, and more Healthcare in 2025, part 2: How AI is shaping care team roles 3 paradigm shifts in healthcare: Cheat sheet series Radio Advisory Tech & AI playlist Survey insights: What to know about the clinician workforce today A transcript of this episode as well as more information and resources can be found on RadioAdvisory.advisory.com.…
Stay tuned to the end of the episode for a policy update on the bill containing Medicaid cuts that is making its way through Congress, and the recent MAHA Commission Report. If you were to ask any healthcare leader what the top challenges in our industry are, it’s a fair bet that “improving patient access to care” would be on the list. There have been so many investments made in the industry to improve access—especially since the Covid-19 pandemic. With this level of investment, we should be moving the needle. But the data shows that access is not getting better, and in some cases, it’s getting worse. This week, Advisory Board physician and medical group expert Mahaya Walker joins host Abby Burns to unpack why, and what medical groups can do about it. They break down Advisory Board research findings around how a narrow focus on improving appointment availability may actually be hurting efforts to improve access, and how medical groups can move the needle on access by putting clinicians closer to the center of their access strategies. Links: Provider availability: A new way to measure access for medical groups Top 3 opportunities to save provider time on administrative tasks Ambulatory access: How to make sustainable progress How to reduce in-basket overload by 34%, in 4 steps 4 ways to improve site-of-care transitions for sickle cell patients How VCU built an ‘inescapable’ Adult Sickle Cell Medical Home to improve inpatient to outpatient transitions of care 4 keys to success in the New England Sickle Cell Institute’s outpatient program for adult sickle cell patients A transcript of this episode as well as more information and resources can be found on RadioAdvisory.advisory.com.…
R
Radio Advisory


1 252: Contain, extract, recover: Inside the Ardent Health cyberattack 41:08
41:08
나중에 재생
나중에 재생
리스트
좋아요
좋아요41:08
In this special live episode from the 2025 Advisory Board Summit, Ardent Health Services President & CEO Marty Bonick and Chief Digital and Transformation Officer Anika Gardenhire recount the harrowing story of a ransomware attack that brought their 30-hospital system to a standstill on Thanksgiving Day 2023. Cyberattacks on healthcare systems are becoming more frequent, more sophisticated, and more devastating. Just 60 days into her role, Anika led the charge to contain the breach, extract the threat, and recover operations in a record-setting 12 days. From ransom messages appearing on medical devices to disconnecting their entire system from the internet, this episode explores what it takes to lead through crisis, act decisively, and build true cyber resilience. This candid conversation underscores why leaders must embrace transparency even when sharing worst-case scenarios. Because learning from difficult moments is how health leaders build stronger, more resilient systems. Links: Ardent Health Cybersecurity in healthcare Paint a picture of a cyber-resilient organization Cybersecurity in healthcare demands resiliency, not reactivity Advisory Board Summits Radio Advisory’s Tech and AI playlist A transcript of this episode as well as more information and resources can be found on RadioAdvisory.advisory.com.…
R
Radio Advisory


1 251: Former HHS leaders weigh in on navigating Trump 2.0 (and answer your questions) 40:25
40:25
나중에 재생
나중에 재생
리스트
좋아요
좋아요40:25
5/22 Update: The House early Thursday narrowly passed the One Big Beautiful Bill Act, a budget bill that includes a number of healthcare provisions that could have a significant impact on Medicaid, Medicare, and the Affordable Care Act. It has been over 100 days since President Donald Trump began his second term. During that time, Radio Advisory has received a steady stream of questions from leaders seeking guidance in an uncertain policy and business environment. With looming funding cuts, the restructure of HHS, the arrival of DOGE and MAHA, and more, leaders are grappling with what to focus on, how to respond, and how to engage productively with the federal government. To help answer these questions, Radio Advisory turned to policy experts from both parties to address your questions, acknowledge your anxieties, and highlight shared opportunities. This week, host Rachel (Rae) Woods welcomes Liz Fowler, former director of the Center for Medicare and Medicaid Innovation under the Biden Administration, and Eric Hargan, former Deputy Secretary of the Department of Health and Human Services during the first Trump term. Together, they discuss how to navigate the shifting policies and priorities of the Trump administration’s second term. Plus, stay tuned to the end of the episode, where co-host Abby Burns discusses the bill proposed by the House Energy and Commerce Committee that would reduce federal Medicaid spending by more than $600 billion over the next ten years. Links: Tracking the Medicaid Provisions in the 2025 Reconciliation Bill | KFF Ep. 244: What’s happened in Washington (so far) and what policy changes we’re bracing for Ep. 230: Elections results are in: What healthcare leaders need to know Thousands laid off at HHS: What you need to know Healthcare policy updates Listen to Radio Advisory’s Health Policy playlist Subscribe to Advisory Board’s Daily Briefing newsletter and get the most important industry news in your inbox – every day. A transcript of this episode as well as more information and resources can be found on RadioAdvisory.advisory.com.…
R
Radio Advisory


1 250: VBC success is possible. Here's how Advocate Health does it. 34:16
34:16
나중에 재생
나중에 재생
리스트
좋아요
좋아요34:16
Believe it or not, 60% of healthcare payments in the US are tied to value. But it’s still surprisingly hard to find examples of health systems that have been doing VBC at scale, successfully, over time. So that’s what Advisory Board researchers set out to do. And across 66 conversations with 44 systems, we found four systems with approaches worth emulating. This week, we’re unpacking the approach at one of those systems: Advocate Health. Host Abby Burns sits down with Don Calcagno, Chief Population Health Officer and President of Advocate’s largest clinically integrated network, Advocate Physician Partners. Don lays out how putting operations at the center has led Advocate to become one of the top-performing systems in Medicare risk models, generate millions of dollars in savings, and, most importantly, improve quality of care. Not to mention, juggle over 100 VBC contracts across 13 accountable care organizations and clinically integrated networks, and carry $1 billion in capitated risk. Links: Read the case study: Inside Advocate Health’s VBC approach that saved $136M VBC self-assessment: Find out where your organization stands 2025 Advisory Board Summit- Carlsbad, CA - join us for the full event, and check out our session featuring another VBC case study Registration is live for our VBC Roundtable in October: HOME - How to deliver the next era of VBC Ep. 243: What’s now and what’s next in value-based care How UNC Health made VBC sustainable in an academic health system Optum Advisory can help you create a VBC strategy for growth and profitability. Connect with an expert. How to succeed in VBC — according to Optum experts VBC success is possible. Here’s how. A transcript of this episode as well as more information and resources can be found on RadioAdvisory.advisory.com.…
R
Radio Advisory


(This episode originally aired on October 22, 2024.) For years, the best word to describe Medicare Advantage (MA) was “untouchable.” Hugely popular among seniors, profitable for health plans—the hybrid public-private payment model grew to the point that it now covers more seniors than traditional Medicare. But in the past few years, the tide has started to change. And if you’ve been paying attention in recent months, you’ll have seen headlines announcing that payers that are scaling back their MA offerings and providers are exiting MA contracts. The MA market has gone from “untouchable” to “volatile.” The question is: why is this happening, and what does it mean for payers, providers, and seniors moving forward? In this episode, hosts Rachel (Rae) Woods and Abby Burns invite health plan experts Max Hakanson and Chelsea Needham to dissect what is going on in MA and how plans and providers are—or should be—navigating the changing tide. Links: Ep. 203: Value series: Is the future of VBC in specialty care? Zing Health & Strive Health say yes. Ep. 149: Senior Care (Part 1): Specialized primary care for an aging population Ep. 150: Senior Care (Part 2): The rapid growth of Medicare Advantage 3 traits health plans want in a provider partner 4 traits providers want in a health plan partner Around the nation: CMS releases Medicare Advantage Star Ratings Q&A: Cardiologist Navin Kapur discusses the future of complex PCI…
R
Radio Advisory


The federal drug purchasing program known as 340B was created in 1992 to help select provider organizations stretch scarce resources to care for patients. More than three decades later, health systems of all shapes and sizes have come to rely on 340B for their financial sustainability. But the program has come under criticism. And in recent years, it’s been under more scrutiny, with manufacturers, state governments, and federal regulators proposing changes to how it operates. In this episode, host Abby Burns invites Advisory Board experts Gina Lohr and Chloe Bakst to unpack the origin and controversy around 340B. They debate whether 340B has strayed from its intended purpose and break down the proposed changes to the program, how likely they are to go into effect, and what those changes would mean for health systems. Plus, stay tuned to the end of the episode, where co-host Rae Woods discusses the recent healthcare-focused executive order and what it signals for the future of this administration’s drug policy. Let us know what you think about today’s discussion, or share your ideas for future episode topics by leaving us a voice message or emailing us . Links: 340B Drug Pricing Program 340B reimbursement cuts may be looming: What you need to know J&J's 340B rebate model is receiving pushback. Here's why. Congress is weighing spending cuts. How will they impact healthcare? [Relentless Health Value] EP448 (Part 1): 340B: Where It Started, Where It Is Now, and Who Is Really Benefiting From This Massive Program, With Shawn Gremminger [Relentless Health Value] EP448 (Part 2): 340B: Why Employers Should Probably Care About What’s Happening Here, With Shawn Gremminger GLP-1 innovation showcase A transcript of this episode as well as more information and resources can be found on RadioAdvisory.advisory.com.…
플레이어 FM에 오신것을 환영합니다!
플레이어 FM은 웹에서 고품질 팟캐스트를 검색하여 지금 바로 즐길 수 있도록 합니다. 최고의 팟캐스트 앱이며 Android, iPhone 및 웹에서도 작동합니다. 장치 간 구독 동기화를 위해 가입하세요.